Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A potential survival benefit in coronary artery bypass grafting with micro-axial temporary pump recovery in patients with reduced left ventricular ejection fraction.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2026
Same author

Long-Term Outcomes of Repeated Transcatheter Aortic Valve Replacement vs Transcatheter Aortic Valve Replacement Explantation: A Nationwide Analysis.

The Annals of thoracic surgery·2026
Same author

Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US.

JAMA cardiology·2026
Same author

Transcatheter Electrosurgery in the Asia-Pacific: Implementation and Innovations.

JACC. Asia·2026
Same author

Sex-specific outcomes following repair of acute type A aortic dissection.

Indian journal of thoracic and cardiovascular surgery·2025
Same author

National Trends in Mitral Valve Surgery Outcomes in Centers With and Without Mitral Transcatheter Edge-to-Edge Repair.

Annals of thoracic surgery short reports·2025
Same journal

miR-19a and miR-20a and Tissue Factor Expression in Activated Human Peripheral Blood Mononuclear Cells.

Thrombosis·2017
Same journal

Referral Patterns and Diagnostic Yield of Lung Scintigraphy in the Diagnosis of Acute Pulmonary Embolism.

Thrombosis·2017
Same journal

Pathogenesis of Thromboembolism and Endovascular Management.

Thrombosis·2017
Same journal

The Typical Presentation Spectrum of Deep Vein Thrombosis Associated with Inferior Vena Cava Malformations.

Thrombosis·2016
Same journal

Out of Sight, out of Mind? An Audit Which Proposes a Follow-Up and Management Pathway for Inferior Vena Cava Filters.

Thrombosis·2016
Same journal

Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases.

Thrombosis·2016
See all related articles

Related Experiment Video

Updated: May 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K

Anticoagulation for prosthetic valves.

Tsuyoshi Kaneko1, Sary F Aranki

  • 1Department of Cardiac Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Thrombosis
|December 5, 2013
PubMed
Summary
This summary is machine-generated.

Warfarin remains the standard for mechanical valve anticoagulation, as newer drugs like dabigatran show increased adverse events. Lowering anticoagulation for On-X valves reduces bleeding without increasing clot risk.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.3K

Related Experiment Videos

Last Updated: May 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.3K

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Pharmacology

Background:

  • Mechanical prosthetic valves necessitate anticoagulation, with warfarin being the current guideline standard.
  • Newer oral anticoagulants, such as dabigatran, offer convenience but have shown increased adverse events in mechanical valve patients.
  • The On-X valve's unique flow dynamics may allow for reduced anticoagulation levels.

Purpose of the Study:

  • To evaluate the safety and efficacy of anticoagulation strategies for mechanical prosthetic valves.
  • To compare warfarin with newer oral anticoagulants in the context of mechanical valve replacement.
  • To assess the impact of reduced anticoagulation levels on outcomes with the On-X valve.

Main Methods:

  • Review of current guidelines and recent clinical trials on anticoagulation for mechanical heart valves.
  • Analysis of studies investigating dabigatran and other novel oral anticoagulants in this patient population.
  • Examination of data on the On-X valve and its associated anticoagulation protocols.

Main Results:

  • Warfarin is recommended for most mechanical valves; dabigatran use is associated with increased adverse events.
  • Lowering anticoagulation intensity for the On-X valve significantly reduces bleeding events.
  • Thromboembolism and thrombosis risks remain comparable between standard and reduced anticoagulation levels for the On-X valve.
  • Anticoagulation management during pregnancy and major bleeding events requires specific protocols, often involving warfarin and heparin derivatives.

Conclusions:

  • Warfarin remains the primary choice for mechanical valve anticoagulation due to safety concerns with newer agents.
  • Reduced anticoagulation may be a viable option for On-X valve recipients to minimize bleeding risk.
  • Careful consideration of anticoagulation is crucial in specific patient populations, including pregnant women and those with a history of bleeding.